• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Detection of drug-induced conformational change of a transmembrane protein in lipid bilayers using site-directed spin labeling

tetano

Editor, Senior Moderator
Protein Sci. 2012 Nov 8. doi: 10.1002/pro.2186. [Epub ahead of print]
Detection of drug-induced conformational change of a transmembrane protein in lipid bilayers using site-directed spin labeling.
Thomaston J, Nguyen PA, Brown EC, Upshur MA, Wang J, Degrado WF, Howard KP.
Source

Department of Chemistry and Biochemistry, Swarthmore College, Swarthmore, PA 19081.
Abstract

As a target of anti-viral drugs, the influenza A M2 protein has been the focus of numerous structural studies and has been extensively explored as a model ion channel. In this study we capitalize on the expanding body of high-resolution structural data available for the M2 protein to design and interpret site-directed spin labeling electron paramagnetic resonance spectroscopy (SDSL-EPR) experiments on drug-induced conformational changes of the M2protein embedded in lipid bilayers. We obtained data in the presence of adamantane drugs for two different M2 constructs (M2TM 22-46 and M2TMC 23-60). M2TM peptides were spin-labeled at the N-terminal end of the transmembrane domain. M2TMC peptides were spin-labeled site-specifically at cysteine residues substituted for amino acids within the transmembrane domain (L36, I39, I42, L43) and the C-terminal amphipathic helix (L46, F47, F48, C50, I51, Y52, R53, F54, F55 and E56). Addition of adamantanedrugsbrought about significant changes in measured EPR environmental parameters consistent with narrowing of the transmembrane channel pore and closer packing of the C-terminal amphipathic helices.

Copyright ? 2012 The Protein Society.

PMID:
23139077
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23139077
 
Back
Top Bottom